UPCOMING SESSIONS in ET
Tue, Sep 8, 2026
5:00 – 6:00 AM Bangkok
Your First Mayo Clinic Evaluation: What to Expect and How to Prepare Cecelia Hernandez Click Here To Register
UPCOMING SESSIONS in ET
Tue, Sep 8, 2026 · 5:00 – 6:00 AM Bangkok
Your First Mayo Clinic Evaluation: What to Expect and How to Prepare
Cecelia Hernandez
Click Here To Register
View all sessions

NICE (UK) positive for Beyonttra (acoramidis) for treating transthyretin amyloidosis with cardiomyopathy – Bayer

Source
Medical Update Online

NICE(UK): Acoramidis can be used, within its marketing authorisation, as an option to treat wild-type or hereditary transthyretin amyloidosis with cardiomyopathy in adults.

Acoramidis can only be used if the company provides it according to the commercial arrangement.